Masanobu Nakajima

8PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)EndodonticsMedical parasitologyEnergy generation, conversion and storage (excl. chemical and electrical)Economic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 17, 2026
Combined organ resection for esophageal cancer invading adjacent organs is becoming a safe and curative procedure.

|Oct 16, 2025
Real-World Effectiveness of Cisplatin, 5-Fluorouracil, and Pembrolizumab Combination Therapy for Unresectable or Recurrent Esophageal Cancer.

Yu Ueta, Masanobu Nakajima, Masaki Yoshimatsu

|Sep 10, 2025
Clinical features of Barrett's mucosa arising in the remnant esophagus after subtotal esophagectomy and esophago-gastric anastomosis for esophageal cancer.

Masanobu Nakajima, Masatoshi Nakagawa, Junki Fujita

|Jun 12, 2023
Laparoscopic Heller myotomy with Dor fundoplication for esophageal achalasia treatment after distal gastrectomy and Billroth-II reconstruction.

Masanobu Nakajima, Norihiro Masuda, Takahiro Shoda

|Apr 15, 2023
Therapeutic strategy aiming at R0 resection for borderline-resectable esophageal squamous cell carcinoma using induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil.

Masanobu Nakajima, Hiroto Muroi, Maiko Kikuchi

|Feb 02, 2022
Dislocation of the gastric conduit reconstructed via the posterior mediastinal route is a significant risk factor for anastomotic disorder after McKeown esophagectomy.

Masanobu Nakajima, Hiroto Muroi, Maiko Kikuchi

Pageof 2

Frequent Collaborators